SUVEN₹261.35-2.55%
40/100
0100 · strongest
moderate
Weights come from configuration, not from this page — each pillar links to the section below that explains it.
Income stmtHistory
Profitability
headline ratiosGrowth
compounded, from filed annual resultsSegment Results
₹ CrWorking Capital & Efficiency
days · ROCE %SUVEN financial summary
For Mar 2026, Suven Life Sciences Ltd reported revenue of ₹7 crore, which grew 0.0% from the previous year. Net profit was -₹55 crore, on an operating margin of -885%. Earnings per share came in at -₹2.08. Annual results are available for 14 financial years, from Mar 2013 to Mar 2026.
| Revenue | ₹7 crore |
|---|---|
| Net profit | -₹55 crore |
| Operating margin | -885% |
| EPS | -₹2.08 |